2019
DOI: 10.1177/2050640619843000
|View full text |Cite
|
Sign up to set email alerts
|

Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites

Abstract: Background: Spontaneous bacterial peritonitis (SBP) is defined as an ascitic polymorphonuclear cell count (A-PMN) > 250 cells/ml. Objective: We aimed to investigate the prognostic value of ascitic fluid cell counts in patients without SBP. Patients and methods: A total of 178 patients were included and stratified by ascitic cell counts at index paracentesis: A-LEUK-low (<250/ml), A-LEUK-intermediate (250-500/ml) and A-LEUK-SBP (>500/ml) for leukocytes; A-PMN-low (<125/ml), A-PMN-intermediate (125-250/ml) and A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 40 publications
0
5
0
Order By: Relevance
“…Over the 13-year study duration (period 1 vs. period 2), patients with SBP presented with more severe clinical disease as reflected by lower serum sodium, higher ascitic fluid polymorphonuclear cell count and higher HRS-AKI prevalence. These factors have all been previously shown to be associated with increased mortality in patients presenting with SBP [30,31,35]. Despite this, mortality at 32 months, inpatient mortality and mortality in those surviving hospitalisation were lower in period 2, although, no statistically significant difference was found.…”
Section: Discussionmentioning
confidence: 88%
“…Over the 13-year study duration (period 1 vs. period 2), patients with SBP presented with more severe clinical disease as reflected by lower serum sodium, higher ascitic fluid polymorphonuclear cell count and higher HRS-AKI prevalence. These factors have all been previously shown to be associated with increased mortality in patients presenting with SBP [30,31,35]. Despite this, mortality at 32 months, inpatient mortality and mortality in those surviving hospitalisation were lower in period 2, although, no statistically significant difference was found.…”
Section: Discussionmentioning
confidence: 88%
“…This study concluded that PMN-C is an independent predictor of subsequent SBP development with a relative risk of 1.352 (1.162–1.499) per 50 cells/mm 3 increase. Another study of 178 subjects stratified by PMN-C at index paracentesis (<125 cells/mm 3 , 125–250 cells/mm 3 , and >250 cells/mm 3 ) also found that patients with PMN-C > 125 cells/mm 3 are at high risk for 1-year mortality, with rates similar to those of patients with SBP ( 37 ). These findings, along with ours, suggest the necessity of lowering the diagnostic threshold of SBP or considering PMN-C ≥ 115 cells/mm 3 as an indication for SBP prophylaxis, given the comparable death rates of patients with PMN-C 115–249 cells/ mm 3 with those of patients with SBP (PMN-C ≥ 250 cells/mm 3 ) who were treated with standard-of-care antibiotics therapy.…”
Section: Discussionmentioning
confidence: 92%
“…As such, ascites PMN count could be a good surrogate marker for a quick tentative diagnosis of SBP, representing clinical outcomes and culture results in advance 11 . The definition of NA as a PMN count ≥250/mm 3 in the fluid has well served for the purpose for more than 30 years although a recent study reported that PMN counts below the traditional SBP threshold were associated with patient outcomes 12 . In contrast, ascites secondary to peritoneal carcinomatosis, are the so‐called MA that result from inflammations or high impedance to lymphatic flow, or both, associated with widespread malignant cells on the surface of the serosal membranes rather than portal hypertension.…”
Section: Discussionmentioning
confidence: 99%